Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Pediatrics in Review|June 30, 2025
The Bleeding Child: Recognizing Inherited Platelet Function DisordersCameron Cooper, Katharine HalliganJournal of Pediatric Hematology/Oncology|February 22, 2017
Acute Liver Failure During Deferasirox Chelation: A Toxicity Worth ConsideringNathan Menaker, Katharine Halligan, Natasha Shur, et al.Journal of Pediatric Hematology/Oncology|February 2, 2023
Successful Treatment of Patient With Ewing Sarcoma in the Setting of Inherited Cholestatic Liver DiseaseJessica Daley, Katharine Halligan, Denise Howrie, et al.Cold Spring Harbor Protocols|June 3, 2010
In ovo live imaging of avian embryosPaul M Kulesa, Caleb M Bailey, Cameron Cooper, et al.Clinical Pediatrics|February 23, 2026
Experiences and Preferences With Pediatric Health Supervision Care Among Family Caregivers of Individuals With Down SyndromeAria C Mallare, Cameron Cooper, Leopoldo Castillo, et al.Sports Health|November 22, 2025
Utilization of Rehabilitation Visits and Functional Testing After Anterior Cruciate Ligament ReconstructionTerese L Chmielewski, Andrea J Lange, Charlie Shervheim, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|August 14, 2025
Elevated Adverse Outcomes in Black Pediatric Burn PatientsJoshua E Lewis, Adannaya Ihediwa, Jordan Kankam, et al.Cureus|March 17, 2025
Morphometric Evaluation of the Anterior Meniscofemoral Ligament in Human Cadaveric Knees: Anatomical Variations and Clinical SignificanceSidnee Wilson, Annabella Awazi, Trayce Gray, et al.Cell Reports|June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilitiesTaylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.Nature Cancer|April 15, 2022
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenomeBrian J Golbourn, Matthew E Halbert, Katharine Halligan, et al.Pageof 2